Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Targeting KK-LC-1 inhibits malignant biological behaviors of triple-negative breast cancer

Fig. 2

Exploration and validation of KK-LC-1 expression. A The Oncomine database was used to analyze Cxorf61 expression in various tumor tissues and adjacent tissues. B Cxorf61 expression was higher in invasive ductal carcinomas. C Cxorf61 expression was higher in phyllodes tumors. D Cxorf61 expression was higher in ductal breast cancer. E Integrative analysis of three studies B, C, and D showed that the expression of Cxorf61 in breast cancer tissues was higher. F, G CCLE database data indicated that Cxorf61 was highly expressed in breast cell lines using both methods (Affy and RNAseq). H The Sangerbox website explores KK-LC-1 mRNA expression in breast cancer and adjacent normal tissues. I The Sangerbox website explores KK-LC-1 mRNA expression in breast cancer and adjacent normal tissues by further integrating data from normal breast tissues in the GTEx database. J The TISIDB database shows KK-LC-1 mRNA expression in different breast cancer molecular subtypes. K, L The expression of KK-LC-1 protein in six pairs of fresh triple-negative breast cancer and adjacent tissues was detected using western blotting

Back to article page